Professor Salman Siddiqui
Chief Investigator
Email: s.siddiqui@imperial.ac.uk
Professor Siddiqui is a Clinical professor of Respiratory and Experimental Medicine at Imperial College London.
Professor Siddiqui is also an honorary NHS consultant at Imperial Healthcare Trust, with specialist expertise in severe asthma and eosinophilic lung disease (in particular EGPA). He is responsible for development of the RACEMATE trial and oversees the study as a whole.
Dr Stephen McAdoo
Co-Investigator
Dr McAdoo holds an Imperial College Clinician Researcher Fellowship, and is an Honorary Consultant Nephrologist at Imperial College Healthcare NHS Trust. His clinical and research interests are in autoimmune kidney diseases, with a particular focus on crescentic glomerulonephritis and systemic vasculitis. He has been actively involved as co-investigator in the RACEMATE Trial.Dr Harold Wilson-Morkeh
Clinical Research Fellow
Harry is a Clinical Research Fellow in Vasculitis at the National Heart and Lung Institute. He is a Sub-Investigator on the RACEMATE trial and involved in patient recruitment and various study-related procedures throughout the trial.Dr Salma Samsuddin
Clinical Trial Manager
Salma is the Trial Manager and oversees the day to day running of this trial.Dr Ana Boshoff
Operations Manager
Email: a.boshoff@imperial.ac.uk
Ana oversees the study from an operational perspective.
Beverly Kowlessar
Clinical Research Nurse
Email: b.kowlessar@nhs.net
Beverly co-coodinates and implements the related procedures.
Dr Anurag Pramanik
Clinical Trials Monitor
Email: a.pramanik@imperial.ac.uk
The Trial Monitor ensures that the trial is being conducted in accordance with trial protocol, trial-specific systems and regulatory guidelines.